Suppr超能文献

30至70岁年龄段人群对白喉和破伤风的免疫力。

Immunity against diphtheria and tetanus in the age group 30-70 years.

作者信息

Kjeldsen K, Simonsen O, Heron I

机构信息

Vaccine Department, State Serum Institute, Copenhagen, Denmark.

出版信息

Scand J Infect Dis. 1988;20(2):177-85. doi: 10.3109/00365548809032435.

Abstract

In Denmark, childhood primary vaccination against diphtheria and tetanus has been recommended since 1950. No routine revaccinations or general vaccination of adults have been offered. In most other western countries revaccinations are recommended later in childhood. However, death still occurs from diphtheria and tetanus in countries with such vaccination programs although it is generally accepted that protective immunity can be obtained by vaccination. On this basis the immunity against diphtheria and tetanus was assessed in a random sample of 351 subjects in the age range 30-70 years. Diphtheria antitoxin titres were determined by in vitro neutralization technique using VERO cells. 26% had diphtheria antitoxin titres below protective level (0.01 international antitoxin units/ml serum). The highest number of unprotected against diphtheria was found among 30-39 year old women (68%) and 60-69 year old subjects (36%). Tetanus titres were determined by a combination of ELISA technique and an in vivo neutralization assay. 51% were unprotected against tetanus (less than 0.01 international antitoxin units/ml serum). The highest number of unprotected against tetanus was found among 60-69 year old subjects (68%) and especially among females in this age group (77%). To avoid epidemics of diphtheria in the future the immunity among adults must be raised within the coming years. Thus, revaccination must be recommended and high attendance ensured. One revaccination is sufficient only when complete primary vaccination is documented.

摘要

在丹麦,自1950年起就建议对儿童进行白喉和破伤风的初级疫苗接种。未提供针对成年人的常规再接种或普遍接种。在大多数其他西方国家,建议在儿童后期进行再接种。然而,在实施此类疫苗接种计划的国家中,白喉和破伤风导致的死亡仍有发生,尽管人们普遍认为通过接种疫苗可获得保护性免疫力。在此基础上,对年龄在30至70岁之间的351名受试者的随机样本进行了白喉和破伤风免疫力评估。使用VERO细胞通过体外中和技术测定白喉抗毒素滴度。26%的人白喉抗毒素滴度低于保护水平(0.01国际抗毒素单位/毫升血清)。未受白喉保护人数最多的是30至39岁的女性(68%)和60至69岁的受试者(36%)。破伤风滴度通过酶联免疫吸附测定(ELISA)技术和体内中和试验相结合的方法测定。51%的人未受破伤风保护(低于0.01国际抗毒素单位/毫升血清)。未受破伤风保护人数最多的是60至69岁受试者(68%),尤其是该年龄组的女性(77%)。为避免未来白喉流行,必须在未来几年内提高成年人的免疫力。因此,必须建议进行再接种并确保高接种率。只有在有完整初级疫苗接种记录的情况下,一次再接种才足够。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验